Drogaria Preco Bom Listed by apos Ransomware Group: Ransomware Claim — What’s Alleged & What To Do
The Drogaria Preco Bom Listed by apos Ransomware Group (reported April 26, 2024) is an unverified claim; the data involved is undisclosed belonging to roughly unknown people. If you have an account with them, your information may now be circulating on the open web and with data brokers. Here’s exactly what happened, how to check if you were affected, and what to do next.
On April 26, 2024, the Brazilian pharmacy operator Drogaria Preco Bom was listed by the ransomware group known as apos. Public reporting indicates that the group claims to have exfiltrated internal files in a ransomware attack, with a reported volume of 5.6 GB of private data associated with the domain bomprecodrogaria.com.br. The number of people affected remains unknown, and independent confirmation of the full scope is limited.
This listing matters because pharmacies routinely handle sensitive personal, health-related, and operational information. When a ransomware group claims to have taken and published internal files, customers, employees, and partners face potential exposure risks even if the precise contents have not been independently verified.
Breaking down the breach
According to available public details, Drogaria Preco Bom appeared on the apos leak site on or around April 26, 2024. The group claims that internal files were exfiltrated during a ransomware attack and that 5.6 GB of private data linked to Brazil and the domain bomprecodrogaria.com.br has been published. No further technical details about the initial access method, the duration of unauthorized access, or the exact timeline of encryption or data theft have been disclosed in the public record.
The number of individuals whose information may be involved is listed as unknown. Beyond the stated claim of internal files and the 5.6 GB figure, no additional file inventories, sample data descriptions, or ransom demands have been made public in the source material. As with most ransomware listings, the group's assertions remain unverified claims until corroborated by the organization or independent investigators.
Inside apos
apos is a ransomware operation that follows the now-common double-extortion model used by many such groups. In this approach, attackers typically gain access to a network, exfiltrate data, encrypt systems, and then threaten to publish the stolen material if a ransom is not paid. Groups operating in this space often maintain dedicated leak sites where they list victims, post sample files, and later release larger archives when negotiations fail or deadlines pass.
Publicly documented activity by apos and similar actors shows a pattern of targeting organizations across multiple sectors and geographies, with listings frequently highlighting the volume of data claimed and the country of the victim. The group does not always provide detailed technical indicators of compromise in its public posts. In the case of Drogaria Preco Bom, the listing itself constitutes the primary public claim; no additional statements attributed specifically to apos about this victim beyond the reported summary have been included in the available facts.
About Drogaria Preco Bom
Drogaria Preco Bom operates in the retail pharmacy sector in Brazil. Organizations of this type typically manage physical and online sales of medicines, personal-care products, and related goods. They commonly maintain customer loyalty programs, prescription records, employee information, supplier contracts, and internal operational documents.
A breach involving a pharmacy chain is consequential because the sector sits at the intersection of retail, healthcare-adjacent services, and personal data processing. Even when only “internal files” are named, the potential for exposure of customer contact details, purchase histories, or staff records creates lasting privacy and security concerns for those connected to the business. The domain referenced in the listing, bomprecodrogaria.com.br, aligns with the organization’s public web presence.
The information in question
The facts state that internal files were exfiltrated in a ransomware attack and that 5.6 GB of private data was published. No more granular inventory of data types—such as customer names, identification numbers, medical information, financial records, or employee files—has been disclosed. The reported summary simply notes private data associated with Brazil and the organization’s domain.
Pharmacies and similar retailers typically hold customer contact information, loyalty-program data, transaction histories, employee personnel files, and internal business documents. Because the exact contents of the claimed 5.6 GB archive remain unconfirmed, it is not possible to state with certainty which of these categories, if any, were included. Readers should treat the group’s description of “private data” as an unverified claim rather than an established inventory.
The real-world impact
For individuals, the primary risks center on potential misuse of any personal information that may have been taken. Even limited internal files can contain names, addresses, phone numbers, or account identifiers that enable phishing, social-engineering attempts, or identity-related fraud. Because the number of people affected is unknown, anyone who has shopped at, worked for, or done business with Drogaria Preco Bom has reason to remain alert for unusual communications that reference the company or request sensitive details.
For the organization, a public ransomware listing can disrupt operations, damage customer trust, and trigger regulatory scrutiny under Brazilian data-protection rules. Recovery typically involves system restoration, forensic review, notification obligations, and long-term monitoring for secondary misuse of any leaked material. The absence of confirmed victim counts or detailed data categories does not eliminate these practical consequences; it simply leaves the full extent of exposure unconfirmed at present.
Were you affected?
If you have a relationship with Drogaria Preco Bom—as a customer, employee, or partner—treat the listing as a signal to take basic protective steps. Monitor financial and email accounts for unexpected activity, be cautious of unsolicited messages that claim to relate to the company, and consider changing passwords used on any related services. Where available, enable multi-factor authentication. Because the precise data involved remains unconfirmed, these measures are precautionary rather than responses to a verified personal exposure.
You can also run a free exposure scan of your email address to check whether it has already appeared in known breach datasets. Such a check will not confirm or rule out involvement in this specific incident, but it can help you identify other exposures that may require attention.
AICompiled with AI assistance from public sources and published under our editorial standards.
How this breach connects
More recent breaches
Drogarias Preço Bom Listed by apos Ransomware GroupBitz Softwares Listed by apos Ransomware GroupACMARK Listed by apos Ransomware GroupInternetWay Listed by apos Ransomware GroupLatest breaches
Read GalaxyWarden’s full analysis of the Drogaria Preco Bom Listed by apos Ransomware Group →
Publicly posted by apos — unverified claim, pending independent verification
Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.
Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.